Gregg L Semenza
Presidente en The Johns Hopkins University School of Medicine .
Perfil
Gregg L Semenza is the Director at the Institute For Cell Engineering.
He is also a Professor of Genetic Medicine at The Johns Hopkins University School of Medicine since 1990.
Additionally, he is a Venture Partner at Catalio Capital Management LP and an Advisor at Medical Excellence Capital LLC.
Semenza holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Cargos activos de Gregg L Semenza
Empresas | Cargo | Inicio |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Inversor de Capital Privado | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Consultor / Asesor | - |
The Johns Hopkins University School of Medicine | Presidente | 01/01/1990 |
Institute For Cell Engineering | Director/Miembro de la Junta | - |
Formación de Gregg L Semenza.
University of Pennsylvania | Doctorate Degree |
Harvard College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
Institute For Cell Engineering |
- Bolsa de valores
- Insiders
- Gregg L Semenza